A single bioanalytical LC-MS/MS method for the quantification of pelitinib across biological matrices: An insight into in vitro metabolic stability, in vivo pharmacokinetics, and IVIVE
Journal of Pharmaceutical and Biomedical Analysis · 2026-11 · 280 · 117622
DOI: 10.1016/j.jpba.2026.117622 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2026-11. Verfasst von Harshada Anil Bhalerao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana 500037, I…. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Liquid Chromatography-Mass Spectrometry, Aniline Compounds, Protein Kinase Inhibitors. Die Arbeit nennt 60 Literaturangaben. Gefördert von: Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India.
Abstract (Originalsprache)
Pelitinib's (PTB) strong, irreversible inhibition of EGFR continues to pique scientific curiosity and warrants investigation of potential therapeutic uses, necessitating reliable analytical methods for its pharmacokinetic and metabolic assessment. Here, we have developed and validated a single, sensitive, and reliable LC-MS/MS (liquid chromatography-tandem mass spectrometry) method in accordance with USFDA guidelines for the quantification of PTB in plasma, human, and rat liver microsomes, where greenness assessment by (Analytical GREEnness metric approach and software) AGREE and (Methodological Overall Green Analytical Procedure Index) MoGAPI tools exhibited a good to moderate environmental performance. Chromatographic separation was achieved on an Agilent Eclipse Plus C18 column using a gradient mobile phase consisting of 0.1% formic acid in water and acetonitrile. Pelitinib exhibited dose-dependent systemic exposure and slow systemic elimination in vivo, along with low intrinsic clearance in microsomal incubations. Hepatic clearance was underestimated relative to the observed pharmacokinetic clearance, according to in vitro-in vivo extrapolation (IVIVE). Further, SwissADME (Swiss Absorption, Distribution, Metabolism, and Excretion) provided additional insights regarding the pharmacokinetic characteristics using in silico predictions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana 500037, India.
- Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana 500037, India. Electronic address: rajesh.sonti@niperhyd.ac.in.
Förderung
- Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India
Zitieren
APA
Bhalerao, H. A., Dhurjad, P., Bharate, A., & Sonti, R. (2026). A single bioanalytical LC-MS/MS method for the quantification of pelitinib across biological matrices: An insight into in vitro metabolic stability, in vivo pharmacokinetics, and IVIVE. Journal of Pharmaceutical and Biomedical Analysis, 280, 117622. https://doi.org/10.1016/j.jpba.2026.117622
Vancouver
Bhalerao HA, Dhurjad P, Bharate A, Sonti R. A single bioanalytical LC-MS/MS method for the quantification of pelitinib across biological matrices: An insight into in vitro metabolic stability, in vivo pharmacokinetics, and IVIVE. Journal of Pharmaceutical and Biomedical Analysis. 2026;280:117622. doi:10.1016/j.jpba.2026.117622
BibTeX
@article{Bhalerao2026,
author = {Bhalerao, Harshada Anil and Dhurjad, Pooja and Bharate, Anish and Sonti, Rajesh},
title = {A single bioanalytical LC-MS/MS method for the quantification of pelitinib across biological matrices: An insight into in vitro metabolic stability, in vivo pharmacokinetics, and IVIVE},
journal = {Journal of Pharmaceutical and Biomedical Analysis},
year = {2026},
volume = {280},
pages = {117622},
doi = {10.1016/j.jpba.2026.117622}
}
EUVIMED